Current price is more than the intrinsic value

Intrinsic Value

Stock has not been able to generate better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 360 in its research report dated November 14, 2022.

Buy Fortis Healthcare; target of Rs 360: Prabhudas Lilladher

BNP Paribas has retained Sun Pharma, Fortis Healthcare and Metropolis as its top pharma stocks picks

BNP Paribas bullish on these Indian pharma stocks post Q2. Its top picks

Last week, IHH and Fortis approached SEBI to proceed with the pending, mandatory takeover offer for the additional 26% stake in Fortis Healthcare

IHH taking legal advice, as SEBI asks it to get Delhi HC order before Fortis open offer

Sebi on Thursday advised Malaysia’s IHH Healthcare to go ahead with its open offer to acquire 26.1 per cent market share in Fortis Healthcare after obtaining order from the Delhi High Court, the company stated. In November 2018,​​ IHH Healthcare had acquired 31.17 per cent stake in Fortis by infusin…

Sebi advices IHH Healthcare to proceed with open offer to acquire stake in Fortis after Delhi HC’s order

Sebi on Thursday advised Malaysia’s IHH Healthcare to go ahead with its open offer to acquire 26.1 per cent market share in Fortis Healthcare after obtaining order from the Delhi High Court, the company stated. In November 2018, IHH Healthcare had acquired 31.17 per cent stake in Fortis by infusing …

Sebi asks IHH Healthcare to proceed with open offer for Fortis after Delhi HC permission

Stocks to watch out for today: LIC, Oil & Natural Gas Corporation, Grasim Industries, IRCTC, Fortis Healthcare, Godrej Properties, EID Parry and more

Stocks in news: LIC, IRCTC, Godrej Properties, Fortis Healthcare and more

Speaking to ET NOW, Dr Ashutosh Raghuvanshi of Fortis Healthcare discussed the Q2 performance of the company, as Sales increase to Rs 1,607 Cr, PAT cross the Rs 200 crore mark and the total occupancy rise to the 70% level. He stated that Q2 is seasonally a good quarter and occupancies are headed towards the 75% level. Moreover, speaking about the possible IHH Healthcare open offer for Fortis, he stated that IHH has conveyed they are actively pursuing regulatory authority to get clarity on the issue, but he cannot comment on the open offer at this point as it is between IHH & shareholders. To know more, watch the video only on ET NOW.
Subscribe To ET Now For Latest Updates On Stocks, Business News, Trading | https://bit.ly/SubscribeToETNow

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow

Pushed via Slike

Fortis Healthcare Q2: Strong Hospital Business, Margins Remain Rangebound | Dr Ashutosh Raghuvanshi

Hindustan Foods Ltd, Brightcom Group Ltd, Force Motors Ltd and Ircon International Ltd are among the other gainers in the BSE’s ‘A’ group today, 14 November 2022.

Fortis Healthcare Ltd leads gainers in ‘A’ group

Shares of Life Insurance Corporation of India (LIC) and Fortis Healthcare surged after companies reported increase in their revenues.

Sensex, Nifty open flat; rupee gains 25 paise against US dollar

Stocks Under Radar on Nov 14: LIC, Nykaa, Fortis Healthcare, BHEL & More

Its Q2FY23 hospital business revenues were at Rs 1,297 crore versus Rs 1,098.5 crore in Q2FY22.

Fortis Healthcare Q2 profit rises 67% to Rs 218 crore

Fortis Healthcare Limited is an integrated healthcare delivery service provider. The Company is engaged in establishing, administering hospitals, diagnostic centers and research centers.

Fortis Healthcare Ltd

Fortis Healthcare Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Fortis Healthcare; target of Rs 360: Prabhudas Lilladher

BNP Paribas bullish on these Indian pharma stocks post Q2. Its top picks

IHH taking legal advice, as SEBI asks it to get Delhi HC order before Fortis open offer

Sebi advices IHH Healthcare to proceed with open offer to acquire stake in Fortis after Delhi HC’s order

Sebi asks IHH Healthcare to proceed with open offer for Fortis after Delhi HC permission

Stocks in news: LIC, IRCTC, Godrej Properties, Fortis Healthcare and more

News Video

Fortis Healthcare Q2: Strong Hospital Business, Margins Remain Rangebound | Dr Ashutosh Raghuvanshi

Fortis Healthcare Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Fortis Healthcare; target of Rs 360: Prabhudas Lilladher

BNP Paribas bullish on these Indian pharma stocks post Q2. Its top picks

IHH taking legal advice, as SEBI asks it to get Delhi HC order before Fortis open offer

Sebi advices IHH Healthcare to proceed with open offer to acquire stake in Fortis after Delhi HC’s order

Sebi asks IHH Healthcare to proceed with open offer for Fortis after Delhi HC permission

Stocks in news: LIC, IRCTC, Godrej Properties, Fortis Healthcare and more

News Video

Fortis Healthcare Q2: Strong Hospital Business, Margins Remain Rangebound | Dr Ashutosh Raghuvanshi

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock